CELUMICRO

Celularity Inc.

HealthcareBiotechnology
$0.88
$0.00(-3.04%)
52W$0.87
$4.35
Updated May 9, 12:00 AM
RSI29
RS Rating7/99
Beta1.40
Volatility106%
F-Score3/9
Mkt Cap$21M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Celularity Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 7), showing significant lag compared to the market leaders. Earnings contraction of 60% provides fundamental context to the price action. Investors should exercise caution due to high volatility (106% annualized), which requires wider risk management.

Relative Strength
7
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.40
vs S&P 500
ABOVE MKT
52W Position
0%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.19
50 SMA > 100 SMA$1.24
100 SMA > 150 SMA$1.46
150 SMA > 200 SMA$1.82

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.08-18.89%BELOW
50 SMA$1.19-26.35%BELOW
100 SMA$1.24-28.93%BELOW
150 SMA$1.46-39.74%BELOW
200 SMA$1.82-51.59%BELOW

Price Performance

1D-3.0%
1W-8.1%
1M-35.8%
3M-32.3%
6M-50.3%
YTD-27.3%
1Y-47.0%
3Y-42.3%
52-Week Trading Range0% from low
$0.88
52W Low$0.87
52W High$4.35

Technical Indicators

RSI (14)OVERSOLD
28.9
305070
VCP ScoreCOOL
3/10
Base depth: 88.5%

Risk Profile

Beta
1.40
52W Vol
106%
ATR
$0.09
Max DD (1Y)
-79%

Volume Analysis

Today
121.1K
50D Avg
191.2K
Vol Ratio
0.63x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25+18%
$-0.84
Q2'25-244%
$-1.02
Q3'25-20%
$-0.88
Q4'25-60%
$-0.95
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+13.21%
3 Years:+13.88%
TTM:-51.03%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-39.22%

Stock Price CAGR

10 Years:-37.58%
5 Years:-61.30%
3 Years:-42.34%
1 Year:-46.99%

Return on Equity

10Y Avg:-188.3%
5Y Avg:-139.0%
3Y Avg:-198.1%
Last Year:

Key Metrics

Market Cap$21M
Gross Margin76.0%
Net Margin-3.5%
Piotroski F-Score3/9

Frequently Asked Questions

Is CELU in an uptrend right now?

CELU has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is CELU overbought or oversold?

CELU's RSI (14) is 29. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.

Is CELU outperforming the market?

CELU has a Relative Strength (RS) Rating of 7 out of 99. CELU is currently lagging the broader market.

Where is CELU in its 52-week range?

CELU is trading at $0.88, which is 20% of its 52-week high ($4.35) and 0% above its 52-week low ($0.87).

How volatile is CELU?

CELU has a Beta of 1.40 and 52-week volatility of 106%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.